Gene · 5169
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. | BMC Cancer | 2023 | 36949462 | PubTator, text mining | PubMed |
| Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects. | World Allergy Organ J | 2023 | 36941898 | PubTator, text mining | PubMed |
| Towards standardizing basophil identification by flow cytometry. | Front Allergy | 2023 | 36938328 | PubTator, text mining | PubMed |
| Strategies for optimizing CITE-seq for human islets and other tissues. | Front Immunol | 2023 | 36936943 | PubTator, text mining | PubMed |
| Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis. | Stem Cells Transl Med | 2023 | 36928395 | PubTator, text mining | PubMed |
| Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis. | Front Genet | 2023 | 36923791 | PubTator, text mining | PubMed |
| Current Practice in Pediatric Cow's Milk Protein Allergy-Immunological Features and Beyond. | Int J Mol Sci | 2023 | 36902457 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D). | Sci Rep | 2023 | 36859467 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| High Infiltration of CD203c+ Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer. | J Inflamm Res | 2023 | 36852299 | PubTator, text mining | PubMed |
| Skin Testing and Basophil Activation Testing Is Useful for Assessing Immediate Reactions to Polyethylene Glycol-Containing Vaccines. | Vaccines (Basel) | 2023 | 36851130 | PubTator, text mining | PubMed |
| SDGs-oriented evaluation of the sustainability of rural human settlement environment in Zhejiang, China. | Heliyon | 2023 | 36846688 | PubTator, text mining | PubMed |
| CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastoma. | Front Oncol | 2023 | 36845728 | PubTator, text mining | PubMed |
| The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections. | Pathogens | 2023 | 36839551 | PubTator, text mining | PubMed |
| Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity Reactions. | Int J Mol Sci | 2023 | 36835299 | PubTator, text mining | PubMed |
| Association between Polymorphisms of Hemochromatosis (HFE), Blood Lead (Pb) Levels, and DNA Oxidative Damage in Battery Workers. | Int J Environ Res Public Health | 2023 | 36834208 | PubTator, text mining | PubMed |
| Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children. | J Allergy Clin Immunol | 2023 | 36828080 | PubTator, text mining | PubMed |
| Lipid transfer protein syndrome in a Northern European patient: An unusual case report. | Front Med (Lausanne) | 2023 | 36824608 | PubTator, text mining | PubMed |
| The C-terminal domains of ADAMTS1 contain exosites involved in its proteoglycanase activity. | J Biol Chem | 2023 | 36813235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5169/papers?page=12